Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 1 003 JPY 6.93%
Market Cap: 28.2B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Foods International Co Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Depreciation & Amortization
ÂĄ907m
CAGR 3-Years
71%
CAGR 5-Years
58%
CAGR 10-Years
43%
GNI Group Ltd
TSE:2160
Depreciation & Amortization
ÂĄ846.8m
CAGR 3-Years
29%
CAGR 5-Years
32%
CAGR 10-Years
36%
PeptiDream Inc
TSE:4587
Depreciation & Amortization
ÂĄ2.3B
CAGR 3-Years
56%
CAGR 5-Years
35%
CAGR 10-Years
40%
Takara Bio Inc
TSE:4974
Depreciation & Amortization
ÂĄ4.7B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
13%
S
StemRIM Inc
TSE:4599
Depreciation & Amortization
ÂĄ44.3m
CAGR 3-Years
1%
CAGR 5-Years
93%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Depreciation & Amortization
ÂĄ70.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
28.1B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 61%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
907m JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Depreciation & Amortization amounts to 907m JPY.

What is Pharma Foods International Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
43%

Over the last year, the Depreciation & Amortization growth was 66%. The average annual Depreciation & Amortization growth rates for Pharma Foods International Co Ltd have been 71% over the past three years , 58% over the past five years , and 43% over the past ten years .

Back to Top